 |
 |
 |
 |
 |
| News Releases |
| News Archives |
| In The Media |
 |
News Releases [+] |
|
Jun 30, 2008
TapImmune Issued U.S. Patent Relating To Method...[+]
TapImmune Inc., (OTCBB: TPIM) announced today the U.S. Patent and Trademark Office (USPTO) has issued U.S. patent No. 7,378,087, entitled “Method of Enhancing an Immune Response.
Jun 9, 2008
TapImmune Announces Execution of Exclusive Opti...[+]
TapImmune Inc. (OTC BB: TPIM), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, today announced that the company has ex...
Jun 2, 2008
Published Third Party, Independent Research Cor...[+]
TapImmune Inc. (OTC BB:TPIM.OB - News), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, today announced that an indepe...
Apr 21, 2008
TapImmune Provides Shareholder Update and Review[+]
TapImmune Inc. (OTC BB:TPIM.OB - News) (Frankfurt:GX1A.F - News) announces completion of initial testing on our bench made vaccine at AppTech.
Jan 22, 2008
Tapimmune Receives Notice Of Allowance For U.S....[+]
TapImmune Inc., (OTCBB: TPIM; Germany: GX1A) announced today the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. patent application No. 10/046,542, entitled “Meth...
Jan 15, 2008
Tapimmune Retains ROI Group as Investor Relatio...[+]
VANCOUVER, BC - January 15, 2008 -- TapImmune Inc. (OTC BB: TPIM), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, tod...
Dec 6, 2007
TapImmune Inc. Announces Granting of U.S. Pat. ...[+]
VANCOUVER, Canada, – TapImmune Inc., (OTCBB: TPIM) (the “Company”) a biotechnology specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, today annou...
Sep 10, 2007
TapImmune Inc. Announces Initiation of Testing ...[+]
,– TapImmune Inc., (OTCBB: TPIM; Germany: GX1A) a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, today announced FDA co...
Aug 15, 2007
TapImmune Inc. Announces Agreement with AppTec ...[+]
TapImmune Inc., (OTCBB: TPIM; Germany: GX1A) a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, today announced a contrac...
Jul 31, 2007
TapImmune Provides Operational Update including...[+]
VANCOUVER, Canada, 31 July, 2007 – TapImmune Inc., a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, opens new laborator...
Jul 17, 2007
TapImmune Inc. Announces Availability of New In...[+]
VANCOUVER, British Columbia, July 17, 2007 (PRIME NEWSWIRE) -- TapImmune Inc., a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious d...
Jun 28, 2007
TapImmune Inc. Announces Acquisition of Core TA...[+]
VANCOUVER, BC – TapImmune Inc. (OTCBB: TPIM), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, announced today that it ...
|
| Designed and Powered by Blender Media Copyright TapImmune 2007 |
Home About Us Technology Publications Investors News Contact Us |